Starbucks: Analyst Consensus Estimates

Starbucks (NASDAQ: SBUX) will be reporting their fiscal second quarter financial results today after the close of markets. Analysts have a consensus $115.05 12-month price target on the company, via a total of 34 analysts, with ten analysts having strong buy ratings. Nine analysts meanwhile have buy ratings and 15 have hold ratings. The street high is a $137 price target, and the lowest target sits at $82.

24 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 24 analysts is $6.8 billion; this number has been revised upwards from $6.7 billion at the start of the year. The highest revenue estimate is $7.47 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently 17 analysts who have second-quarter EBITDA estimates. The mean is currently $1.27 billion, with this number having been revised down from $1.35 billion at the start of the year. The street high estimate currently sits at $1.36 billion in EBITDA and the lowest is $1.17 billion.

Analysts estimate that quarterly earnings per share will come in at $0.52, with this number being slightly revised down from $0.59 at the start of the year. Street high currently sits at $0.59 in earnings per share, while the lowest estimate is $0.47 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Related News

Canaccord: 2020 To Be Transition Year For Medipharm Labs

Last week, Medipharm Labs (TSX: LABS) reported their second-quarter earnings. Revenue came in at $13.9...

Saturday, August 22, 2020, 01:38:00 PM

Starbucks: Analysts Raise Targets Following Q2 Results

Starbucks (NASDAQ: SBUX) opened 3% lower on the 28th before rallying on Thursday’s trading day...

Sunday, May 2, 2021, 01:18:00 PM

CN Rail: BMO Anticipates Continued Strong Earnings

Canadian National Railway (TSX: CNR) last week released its third-quarter financial and operating results. The...

Thursday, November 3, 2022, 04:38:00 PM

Verano Holdings: Canaccord Initiates With $35 Price Target

Earlier this month Canaccord initiated coverage on Verano Holdings (CSE: VRNO) with a C$35 price...

Monday, March 22, 2021, 10:41:00 AM

Canaccord Drops Medmen Price Target To $0.00, Reiterates Sell Rating

After Medmen Enterprises’ (CSE: MMEN) fourth-quarter results dropped after hours on October 15th, Canaccord downgraded...

Friday, October 16, 2020, 12:22:53 PM